🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The The Telegraph highlights #EpiSwitchPSE as a next-gen test reducing false positives in #ProstateCancer testing. Better testing ➡️ earlier diagnosis ➡️ better outcomes. 📖 Read more: mypse.co/ld8. #EarlyDetectionSavesLives

If anyone is looking to improve on health and fitness, why not give my eldest son a follow on insta. DM him to get a personalised diet and training plan. instagram.com/reel/DKKTVOAIX…

Am a shareholder from higher levels on #OBD & believe to be v compelling under-radar story. A 94% accurate prostate cancer blood test (best in world?), now backed by BUPA & 160+ UK clinics. MCap ~£7m + at early stage in potentially exciting commercial journey

#OBD positive movement here. Number one on the risers board 👀 £7m Cap and any whiff of a deal would be multiples

Coinsilium is pleased to announce that due to the level of demand received, the Company has decided to close the WRAP Retail Offer early. A further announcement will be made on Monday, 2 June 2025, regarding the total proceeds and the number of Ordinary Shares to be issued

Over the past few decades, cancer research has made incredible strides—including advances in blood-based testing for prostate cancer. Innovations like the EpiSwitch® PSE test are part of that progress, offering new ways to detect prostate cancer earlier and less invasively.

#OBD Oxford BioDynamics Interview with Senior Commercial Director ‘This company has unlocked 3G Genomics in a way that multi-billion dollar pharma in the US have just not managed to do’ #episwitch #prostatecancer #biotech #pharma youtu.be/EGh1-fEaiso?si…

#obd going to be massive on Monday

#OBD great interview! 'OBD have achieved what multi billion dollar pharma in the US has failed to achieve' £8.5m Cap. Ripe for deal flow sounds like x.com/smallcappixuk/…

#COIN Get in before the train Bitcoin train leaves the station !

Immunotherapy has transformed cancer care. During National Cancer Research Month, we’re spotlighting how tools like EpiSwitch® CiRT are helping move us toward more precise, personalized treatments. Learn more: mycirt.co/99l. #NationalCancerResearchMonth #NCRM25

#OBD Oxford BioDynamics One of the most interesting interviews I have done. They have something unique here - a platform to develop market leading precision cancer diagnostics tests The opportunity vs current company valuation of just £8.5m is astounding imo

We are very pleased, OAK raised all the money in the £2.5m placing and have put a leading UK small cap fund manager on the register.

Excellent interview with Bartu Ahiska from #OBD, well worth a watch for any potential investors #ProstateCancer

#COIN leading UK small cap fund manager on the register.

We appreciate your support in helping make precision #diagnostics more accessible. It’s exciting to see the #OBD #EpiSwitchPSE test making a real impact in clinics across the UK — a big step forward for early #ProstateCancer detection. 94percent.com

#OBD an overview of their products and IP With EpiSwitch, their 3D genomics platform, the future possibilities are endless smallcappix.com/blogdetail?id=…

#OBD very interesting interview here from SmallCapPix 💰 𝑺𝒑𝒐𝒏𝒈𝒆 💰 £8m market cap and it sounds to me like partnerships will be what sends this north in the future. Focus now is clearly on driving direct sales and securing strategic partnerships with pharma and

#UOG🎙️In this interview with Charles Archer, CEO Brian Larkin talks Jamaica — and why the piston core survey could significantly change the risk profile of the licence 🔹Multiple parties under NDA, farm-out talks progressing incorporating work programme into farm-out discussions